Updated PFS May Pave Way to Partnership
Source: Streetwise Reports  (7/13/22)
A simpler open-pit only mine plan for Seabridge Gold’s massive KSM copper-gold project in northern B.C. could attract a joint-venture partner. But it might not be the company you think. More >

EV Maker Signs Agreement With Walmart for Up to 10,000 LDVs
Source: Streetwise Reports  (7/12/22)
Shares of Canoo Inc. traded 57% higher after the company reported that Walmart has contracted to purchase 4,500 of its electric Lifestyle Delivery Vehicles for use in its growing e-commerce business. The agreement includes an option for 5,500 additional units. More >

Three Analysts Like Healthcare Co.'s Upside
Source: Streetwise Reports  (7/11/22)
It is difficult to get three people to agree on anything, let alone three investment analysts. But that is precisely the case with one junior biotech company that has shown in a clinical trial that its ketamine-assisted therapy for alcohol use disorder (AUD) is three times more effective than the current standard of care. More >

Pharma Looks To Improve Potential Psychedelic Stroke Drug
Source: Streetwise Reports  (7/11/22)
Can a psychedelic compound help you heal after a stroke? This biopharmaceutical company hopes it can and plans to start Phase 1 trials this September. More >

EV Co. Secures Huge No. of Orders for Off-Road Vehicle
Source: Streetwise Reports  (7/11/22)
Shares of Volcon Inc. traded 47% after the all-electric powersports company reported that over the course of just 14 days it received thousands of pre-orders for its class-leading 125 hp Stag EV. The orders are expected to provide the firm with an additional $70 million in revenue. More >

Gold Co. Positioned To Be Next Tier One Asset in Ontario
Source: Maurice Jackson  (7/11/22)
Expert Maurice Jackson sits down with the CEO of Goldshore Resources Inc., Brett Richards to go over the latest updates with the company. With just one year under its belt, Goldshore Resources is already positioning itself to become the next tier one asset in Ontario. The flagship Moss Lake Property has a historical resource with significant expansion potential and is currently undergoing a 100,000-meter drill program, with impressive initial assay results. More >

Altius Invests in Lara Exploration
Source: Adrian Day  (7/11/22)
Expert Adrian Day reviews updates at some of his favorite companies, including most recently the news between Altius Minerals Corp. and Lara Exploration Ltd.'s relationship. More >

Oil Price Problem? Expert Says Look to 2011
Source: Michael J. Ballanger  (7/11/22)
Expert Michael Ballanger reviews this week's updates in the oil and gas sector, specifically his view on the U.S. government's handling of sanctions against Russia and how that will impact the economy. More >

New Drug Is Shown to Help Stopped or Reduced Bile Flow
  (7/10/22)
Albireo Pharma Inc.'s positive Phase 3 trial results indicate the medication would afford patients clinical and quality of life benefits, noted an H.C. Wainwright & Co. report. More >

New DMD Drug Yields 'Compelling' Data
  (7/9/22)
A statistical reanalysis of trial results from Sarepta Therapeutics Inc. shows improved patient function, noted an Oppenheimer report. More >

Amended Agreement to Benefit Two Biotech Firms
  (7/8/22)
In the new arrangement between Beam Therapeutics Inc. and Verve Therapeutics Inc. each of the companies grants the other an exclusive license, one to a base editing target, the other to a gene delivery technology, noted a Wedbush report. More >

Today’s Bear Market Lowers the Risk on New Gold Discoveries
Source: Matt Badiali  (7/8/22)
Independent financial analyst Matt Badiali reviews the current bear market in junior mining stocks, profiling Vizsla Silver, Arizona Sonoran Copper Company, and Cross River Ventures Corp. to tell you which stock's risks are worth the reward. More >

Is KRL the Next K92?
Source: Streetwise Reports  (7/7/22)
This morning, newsletter writer Bob Moriarty, after not writing about a junior mining stock since early June, published an opinion piece on KRL Resources — and came out with a Buy recommendation on the junior. More >

Co. Makes Financing Deals Around Two of Its Approved Drugs
  (7/7/22)
The agreements include milestone payments based on future revenue from sales of the biopharma Blueprint Medicines Corp.'s therapies, noted a Wedbush report. More >

Mine Operator Locks In High Copper Prices for 2023
Source: Streetwise Reports  (7/7/22)
Taseko Mines Ltd.'s shares traded 10% higher after the mine developer and operator reported that last month prior to the recent downturn in raw copper prices it had secured contracts for H1/23 for an additional 30Mlb Cu at prices ranging from $3.75-4.20/lb More >

Wealth Minerals Raises Cash, Drills Lithium Play in Chile
Source: Streetwise Reports  (7/6/22)
As money dries up for a lot of mineral exploration, it seems that investors will still write checks for lithium plays. One junior with two lithium projects in Chile recently raised over $3 million — and the investors approached the company. More >

Copper's Future Still Bright in Colombia, Analyst Says
Source: Streetwise Reports  (7/6/22)
The leftist president-elect of Colombia has promised to halt new gas and oil development. But the government has highlighted the importance of finding new forms of energy for the green transition, and one analyst says copper will play a big role in that future. More >

Strong Data Suggest FDA Will Approve New Lymphoma Drug
  (7/6/22)
A green light is expected for the treatment after its developers submit a biologics license application for it, planned for H2/22, noted an H.C. Wainwright & Co. report. More >

Gold Terra Hits Campbell Shear at Depth for the First Time
Source: The Critical Investor  (7/6/22)
The Critical Investor discusses the first results of deep drilling aimed at the Campbell Shear with CEO Gerald Panneton. More >

Renewable Energy Products Co. Posts 285% Sales Growth in H1
Source: Streetwise Reports  (7/6/22)
Shares of Ozop Energy Solutions Inc. traded 23% higher after the company reported that H1/22 revenues are expected to be 285% higher versus the same period last year. The firm advised that it anticipates further sequential growth in H2/22. More >

The FDA Is Expected to Approve New Narcolepsy Drug
  (7/5/22)
Avadel Pharmaceuticals Plc., the biopharma company behind this treatment, is currently undervalued and rated Outperform, noted an Oppenheimer report. More >

The Return of the Northern Peso
Source: Michael J. Ballanger  (7/5/22)
Expert Michael Ballanger reviews recent movements in the mining and precious metals market and what moves he plans on making as we wait and see whether the Fed will pivot. More >

What Is the Risk of More Downturn?
Source: Adrian Day  (7/5/22)
Expert Adrian Day looks at the state of the market after this year’s 23% decline and discusses the risk of more possible downturn. Find out which companies he thinks are a buy — and which ones need to fly off your radar. More >

Laser Device Co. Gains FDA Approval for Next-Gen Catheter
Source: Streetwise Reports  (7/5/22)
Ra Medical Systems Inc. shares traded 36% higher after the firm reported it received U.S. FDA 510(k) clearance for its DABRA 2.0 Catheter. The DABRA 2.0 is incorporated into the company's DABRA Excimer Laser System which is used by vascular surgeons in procedures to treat lower extremity and peripheral vascular disease. More >

BC Junior Starts Mining Placer Gold
Source: Streetwise Reports  (7/4/22)
You've seen placer gold being mined on Gold Rush, Discovery's gold mining TV show. But one junior explorer just announced that it's started to commercially mine placer gold in south-central British Columbia from a pay channel underneath Lightning Creek. At least one analyst thinks that makes this junior a Speculative Buy. More >